Clinical trial
Survivorship Promotion In Reducing IGF-1 Trial
NCT02431676
Study timeline
Study start (actual)2015-05-01Date precision: month
Registry last updated2024-08-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Prostate Cancerunresolved
Lung Cancerunresolved
Colon Cancerunresolved
Melanoma of Skinunresolved
Endometrial Cancerunresolved
Liver Cancerunresolved
Pancreatic Cancerunresolved
Rectal Cancerunresolved
Kidney Cancerunresolved
Other Solid Malignant Tumorsunresolved
Interventions
MetforminDRUG · verified · RxNorm: metformin
Coach Directed Behavioral Weight LossBEHAVIORAL
Self-control weight lossBEHAVIORAL
Sponsors & collaborators
Maryland Cigarette Restitution Fundcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02431676 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.